Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency
- PMID: 11154146
Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency
Abstract
Prothrombin deficiency is an autosomal recessive disorder associated with a moderately severe bleeding tendency. In this study, 13 patients with prothrombin deficiency were screened for the presence of alterations in the prothrombin gene, and nine novel candidate mutations were identified. Of 11 patients with hypoprothrombinemia, ten are homozygous for five mutations and one patient is a compound heterozygote. The two patients with dysprothrombinemia are homozygous for two mutations. Eight of nine mutations are missense ones associated with single amino acid substitutions in the propeptide (Arg-1Gln, Arg-2Trp), the kringle-1 (Asp118Try) and kringle-2 (Arg220Cys) domains and the catalytic serine protease domain (Gly330Ser, Ser354Arg. Arg382His and Arg538Cys). The ninth mutation is an in-frame deletion of 3 bp that results in the omission of one amino acid (del Lys 301/302). The combination of these missense mutations with crystal structures for alpha-thrombin and the prothrombin fragments 1 and 2 resulted in new insight into the function of alpha-thrombin. The hypoprothrombinemia mutations were inferred to affect either the cleavage of the propeptide from the Gla domain, the stability of the kringle-1 and -2 domains, or the close association of the A and B chains of the serine protease domain. The dysprothrombinemia mutations were inferred to directly affect catalytic function through their location at the active site crevice or exosite 1 within the serine protease domain.
Similar articles
-
Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency.Thromb Haemost. 2000 Aug;84(2):250-7. Thromb Haemost. 2000. PMID: 10959697
-
A severe neonatal presentation of factor II deficiency.Eur J Haematol. 2011 Nov;87(5):464-6. doi: 10.1111/j.1600-0609.2011.01670.x. Epub 2011 Aug 11. Eur J Haematol. 2011. PMID: 21692854
-
Congenital prothrombin deficiency.Semin Thromb Hemost. 2009 Jun;35(4):367-81. doi: 10.1055/s-0029-1225759. Epub 2009 Jul 13. Semin Thromb Hemost. 2009. PMID: 19598065 Review.
-
Identification of 16 novel mutations in the argininosuccinate synthetase gene and genotype-phenotype correlation in 38 classical citrullinemia patients.Hum Mutat. 2003 Jul;22(1):24-34. doi: 10.1002/humu.10230. Hum Mutat. 2003. PMID: 12815590
-
Congenital prothrombin deficiency: an update.Semin Thromb Hemost. 2013 Sep;39(6):596-606. doi: 10.1055/s-0033-1348948. Epub 2013 Jul 12. Semin Thromb Hemost. 2013. PMID: 23852823 Review.
Cited by
-
Dual effect of histone H4 on prothrombin activation.J Thromb Haemost. 2016 Sep;14(9):1814-8. doi: 10.1111/jth.13400. Epub 2016 Aug 11. J Thromb Haemost. 2016. PMID: 27359051 Free PMC article.
-
Light Chain Mutation Effects on the Dynamics of Thrombin.J Chem Inf Model. 2021 Feb 22;61(2):950-965. doi: 10.1021/acs.jcim.0c01303. Epub 2021 Jan 15. J Chem Inf Model. 2021. PMID: 33450154 Free PMC article.
-
Thrombin.Mol Aspects Med. 2008 Aug;29(4):203-54. doi: 10.1016/j.mam.2008.01.001. Epub 2008 Feb 1. Mol Aspects Med. 2008. PMID: 18329094 Free PMC article. Review.
-
An in vitro anticoagulant effect of Fenugreek (Trigonella foenum-graecum) in blood samples of normal Sudanese individuals.Sudan J Paediatr. 2013;13(2):52-6. Sudan J Paediatr. 2013. PMID: 27493374 Free PMC article.
-
Na+-binding modes involved in thrombin's allosteric response as revealed by molecular dynamics simulations, correlation networks and Markov modeling.Phys Chem Chem Phys. 2019 Feb 20;21(8):4320-4330. doi: 10.1039/c8cp07293k. Phys Chem Chem Phys. 2019. PMID: 30724273 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical